AU2001259816A1 - Polyhydroxy glycopeptide derivatives - Google Patents
Polyhydroxy glycopeptide derivativesInfo
- Publication number
- AU2001259816A1 AU2001259816A1 AU2001259816A AU5981601A AU2001259816A1 AU 2001259816 A1 AU2001259816 A1 AU 2001259816A1 AU 2001259816 A AU2001259816 A AU 2001259816A AU 5981601 A AU5981601 A AU 5981601A AU 2001259816 A1 AU2001259816 A1 AU 2001259816A1
- Authority
- AU
- Australia
- Prior art keywords
- polyhydroxy
- glycopeptide derivatives
- glycopeptide
- derivatives
- polyhydroxy glycopeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21342800P | 2000-06-22 | 2000-06-22 | |
US60213428 | 2000-06-22 | ||
PCT/US2001/040648 WO2001098329A1 (en) | 2000-06-22 | 2001-05-01 | Polyhydroxy glycopeptide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001259816A1 true AU2001259816A1 (en) | 2002-01-02 |
Family
ID=22795088
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001259816A Abandoned AU2001259816A1 (en) | 2000-06-22 | 2001-05-01 | Polyhydroxy glycopeptide derivatives |
Country Status (3)
Country | Link |
---|---|
US (1) | US6828299B2 (en) |
AU (1) | AU2001259816A1 (en) |
WO (1) | WO2001098329A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001083520A2 (en) | 2000-05-02 | 2001-11-08 | Theravance,Inc | Polyacid glycopeptide derivatives |
ATE416791T1 (en) | 2000-05-02 | 2008-12-15 | Theravance Inc | COMPOSITION CONTAINING A CYCLODEXTRIN AND A GLYCOPEPTIDE ANTIBIOTIC |
AU2001259303A1 (en) | 2000-06-22 | 2002-01-02 | Advanced Medicine, Inc. | Glycopeptide carboxy-saccharide derivatives |
UA75083C2 (en) | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Derivatives of glycopeptidephosphonates |
US6872804B2 (en) | 2000-06-22 | 2005-03-29 | Theravance, Inc. | Glycopeptide disulfide and thioester derivatives |
TWI275594B (en) * | 2001-08-24 | 2007-03-11 | Theravance Inc | Process for preparing vancomycin phosphonate derivatives |
US7287325B2 (en) * | 2005-05-10 | 2007-10-30 | International Business Machines Corporation | Method of forming interconnect structure or interconnect and via structures using post chemical mechanical polishing |
US7473636B2 (en) * | 2006-01-12 | 2009-01-06 | International Business Machines Corporation | Method to improve time dependent dielectric breakdown |
CN101410012A (en) | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin |
WO2007112272A2 (en) * | 2006-03-28 | 2007-10-04 | Javelin Pharmaceuticals, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
BR112014001335A2 (en) | 2011-07-20 | 2017-02-21 | Hospira Inc | method for treating postoperative pain in a mammal and method for treating pain in a mammal |
US10037528B2 (en) | 2015-01-14 | 2018-07-31 | Tactilis Sdn Bhd | Biometric device utilizing finger sequence for authentication |
US10395227B2 (en) | 2015-01-14 | 2019-08-27 | Tactilis Pte. Limited | System and method for reconciling electronic transaction records for enhanced security |
US9607189B2 (en) | 2015-01-14 | 2017-03-28 | Tactilis Sdn Bhd | Smart card system comprising a card and a carrier |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
US4698327A (en) | 1985-04-25 | 1987-10-06 | Eli Lilly And Company | Novel glycopeptide derivatives |
US4643987A (en) | 1985-08-14 | 1987-02-17 | Eli Lilly And Company | Modified glycopeptides |
US5002935A (en) | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
IL96603A (en) | 1989-12-13 | 1998-02-08 | Lilly Co Eli | Antibacterial glycopeptide derivatives, process for their preparation and pharmaceutical compositions containing them |
US5750509A (en) | 1991-07-29 | 1998-05-12 | Gruppo Lepetit S.P.A. | Amide derivatives of antibiotic A 40926 |
US5602112A (en) | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
AU672862B2 (en) | 1992-12-02 | 1996-10-17 | Insite Vision Incorporated | Cyclodextrin and polymer based drug delivery system |
US5840684A (en) | 1994-01-28 | 1998-11-24 | Eli Lilly And Company | Glycopeptide antibiotic derivatives |
PE40996A1 (en) | 1994-01-28 | 1996-10-14 | Lilly Co Eli | ANTIBIOTIC DERIVATIVE OF GLUCOPEPTIDE |
US5919756A (en) | 1996-06-28 | 1999-07-06 | Eli Lilly And Company | Amides |
US5916873A (en) | 1997-04-17 | 1999-06-29 | Eli Lilly And Company | Teicoplanin derivatives |
WO2000004044A1 (en) | 1998-07-14 | 2000-01-27 | Princeton University | Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same |
HU230190B1 (en) | 1998-12-23 | 2015-09-28 | Theravance, Inc | Glycopeptide derivatives and pharmaceutical compositions containing the same |
DE19911097A1 (en) | 1999-03-12 | 2000-09-14 | Basf Ag | Process for the preparation of solid dosage forms containing cyclodextrin |
WO2000059528A1 (en) | 1999-04-02 | 2000-10-12 | The Trustees Of Princeton University | Desleucyl glycopeptide antibiotics and methods of making same |
WO2001083520A2 (en) | 2000-05-02 | 2001-11-08 | Theravance,Inc | Polyacid glycopeptide derivatives |
UA82824C2 (en) | 2000-06-21 | 2008-05-26 | К'Юбіст Фармасьютікалз, Інк. | Compositions and methods to improve the oral absorption of antimicrobial agents |
AU2001259302A1 (en) | 2000-06-22 | 2002-01-02 | Yongqi Mu | Glycopeptide disulfide and thioester derivatives |
AU2001259303A1 (en) | 2000-06-22 | 2002-01-02 | Advanced Medicine, Inc. | Glycopeptide carboxy-saccharide derivatives |
UA75083C2 (en) | 2000-06-22 | 2006-03-15 | Тераванс, Інк. | Derivatives of glycopeptidephosphonates |
-
2001
- 2001-05-01 AU AU2001259816A patent/AU2001259816A1/en not_active Abandoned
- 2001-05-01 WO PCT/US2001/040648 patent/WO2001098329A1/en active Application Filing
- 2001-05-01 US US09/847,061 patent/US6828299B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US6828299B2 (en) | 2004-12-07 |
US20020049156A1 (en) | 2002-04-25 |
WO2001098329A1 (en) | 2001-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001280099A1 (en) | 4-acylaminopyrazole derivatives | |
AU2001246835A1 (en) | Ethylenediamine derivatives | |
AU2001230584A1 (en) | 1h-imidazopyridine derivatives | |
AU2001232799A1 (en) | Protein c derivatives | |
AU2001269503A1 (en) | Amino alcohol derivatives | |
AU2001256769A1 (en) | Triazole derivatives | |
AU2001230537A1 (en) | Pyridoxazine derivatives | |
AU2001281802A1 (en) | 6-phenylpyrrolopyrimidinedione derivatives | |
AU2001278790A1 (en) | 1h-imidazopyridine derivatives | |
AU2001231664A1 (en) | Indol-3-yl derivatives | |
AU2001278694A1 (en) | Avermectin derivatives | |
AU2002223503A1 (en) | Decondenser unit | |
AU2001259816A1 (en) | Polyhydroxy glycopeptide derivatives | |
AU2002213978A1 (en) | Substituted C-cyclohexylmethylamine derivatives | |
AU2002212301A1 (en) | Diazacycloalkanedione derivatives | |
AU5256301A (en) | Froindazole derivative | |
AU2002212959A1 (en) | Cycloalkylfluorosulfonamide derivatives | |
AU2001259298A1 (en) | Polyacid glycopeptide derivatives | |
AU2002215212A1 (en) | 1-methylcarbapenem derivatives | |
AU2001289937A1 (en) | Substituted 1-aminobutan-3-ol derivatives | |
AU2001230565A1 (en) | Perfluoroisopropylbenzene derivatives | |
AU2001254661A1 (en) | Aminosulfonylbiphenyl derivatives | |
AU2001234313A1 (en) | Novel phenylheteroalkylamine derivatives | |
AU2001223813A1 (en) | Personalized hardware | |
AU2001220281A1 (en) | Rollerboard for road-skiing |